In CRC cell lines, miR-320b was found to target MYC to suppress cell proliferation [105] while miR-331-3p besides inhibiting proliferation additionally stimulates apoptosis by targeting HER2 through activation of the PI3K/Akt and ERK1/2 pathways [106]. Here, ERBB2 is linked to colorectal carcinoma.